Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

Similar articles for PubMed (Select 15149588)

1.

Control of DNA synthesis and mitosis by the Skp2-p27-Cdk1/2 axis.

Pagano M.

Mol Cell. 2004 May 21;14(4):414-6. Review.

2.

Skp2-mediated degradation of p27 regulates progression into mitosis.

Nakayama K, Nagahama H, Minamishima YA, Miyake S, Ishida N, Hatakeyama S, Kitagawa M, Iemura S, Natsume T, Nakayama KI.

Dev Cell. 2004 May;6(5):661-72.

3.

A second RING to destroy p27(Kip1).

Hengst L.

Nat Cell Biol. 2004 Dec;6(12):1153-5. No abstract available.

PMID:
15573093
4.
5.

Skp2-dependent degradation of p27kip1 is essential for cell cycle progression.

Kossatz U, Dietrich N, Zender L, Buer J, Manns MP, Malek NP.

Genes Dev. 2004 Nov 1;18(21):2602-7.

6.

Tuberin binds p27 and negatively regulates its interaction with the SCF component Skp2.

Rosner M, Hengstschläger M.

J Biol Chem. 2004 Nov 19;279(47):48707-15. Epub 2004 Sep 8.

7.

Two E3 ubiquitin ligases, SCF-Skp2 and DDB1-Cul4, target human Cdt1 for proteolysis.

Nishitani H, Sugimoto N, Roukos V, Nakanishi Y, Saijo M, Obuse C, Tsurimoto T, Nakayama KI, Nakayama K, Fujita M, Lygerou Z, Nishimoto T.

EMBO J. 2006 Mar 8;25(5):1126-36. Epub 2006 Feb 16.

8.

Notch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27 Kip1 degradation.

Sarmento LM, Huang H, Limon A, Gordon W, Fernandes J, Tavares MJ, Miele L, Cardoso AA, Classon M, Carlesso N.

J Exp Med. 2005 Jul 4;202(1):157-68.

9.

Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex.

Wei W, Ayad NG, Wan Y, Zhang GJ, Kirschner MW, Kaelin WG Jr.

Nature. 2004 Mar 11;428(6979):194-8.

10.

Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative disease.

Agarwal A, Bumm TG, Corbin AS, O'Hare T, Loriaux M, VanDyke J, Willis SG, Deininger J, Nakayama KI, Druker BJ, Deininger MW.

Blood. 2008 Sep 1;112(5):1960-70. doi: 10.1182/blood-2007-09-113860. Epub 2008 Jun 17.

11.

Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase.

Wang IC, Chen YJ, Hughes D, Petrovic V, Major ML, Park HJ, Tan Y, Ackerson T, Costa RH.

Mol Cell Biol. 2005 Dec;25(24):10875-94.

12.

Small interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p27 degradation.

Kudo Y, Kitajima S, Ogawa I, Kitagawa M, Miyauchi M, Takata T.

Mol Cancer Ther. 2005 Mar;4(3):471-6.

13.

Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.

Auld CA, Fernandes KM, Morrison RF.

J Cell Physiol. 2007 Apr;211(1):101-11.

PMID:
17096381
14.

The F box protein S phase kinase-associated protein 2 regulates adipose mass and adipocyte number in vivo.

Cooke PS, Holsberger DR, Cimafranca MA, Meling DD, Beals CM, Nakayama K, Nakayama KI, Kiyokawa H.

Obesity (Silver Spring). 2007 Jun;15(6):1400-8.

PMID:
17557977
15.
16.

Skp2 inversely correlates with p27 and tuberin in transformed cells.

Rosner M, Hanneder M, Siegel N, Valli A, Fuchs C, Hengstschläger M.

Amino Acids. 2009 Jul;37(2):257-62. doi: 10.1007/s00726-008-0141-7. Epub 2008 Jul 6.

PMID:
18604603
17.
18.

Down-regulation of SKP2 induces apoptosis in lung-cancer cells.

Yokoi S, Yasui K, Iizasa T, Takahashi T, Fujisawa T, Inazawa J.

Cancer Sci. 2003 Apr;94(4):344-9.

PMID:
12824902
19.

Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate.

Shim EH, Johnson L, Noh HL, Kim YJ, Sun H, Zeiss C, Zhang H.

Cancer Res. 2003 Apr 1;63(7):1583-8.

20.

Renal damage in obstructive nephropathy is decreased in Skp2-deficient mice.

Suzuki S, Fukasawa H, Kitagawa K, Uchida C, Hattori T, Isobe T, Oda T, Misaki T, Ohashi N, Nakayama K, Nakayama KI, Hishida A, Yamamoto T, Kitagawa M.

Am J Pathol. 2007 Aug;171(2):473-83. Epub 2007 Jul 9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk